NLRC3 Is an Inhibitory Sensor of PI3K–mTOR Pathways in Cancer

Nature - United Kingdom
doi 10.1038/nature20597
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Pd32-09 Combination Effect of Therapies Targeting the Pi3k-Mtor and Ar Signaling Pathways in Prostate Cancer

Journal of Urology
Urology
2016English

NRSN2 Promotes Breast Cancer Metastasis by Activating PI3K/AKT/mTOR and NF‑κB Signaling Pathways

Oncology Letters
Cancer ResearchOncology
2019English

PI3K/PTEN/Akt and TSC/mTOR Signaling Pathways, Ovarian Dysfunction, and Infertility: An Update

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2014English

DOK7V1 Influences the Malignant Phenotype of Lung Cancer Cells Through PI3K/AKT/mTOR and FAK/paxillin Signaling Pathways

International Journal of Oncology
Cancer ResearchOncology
2018English

JTC-801 Suppresses Melanoma Cells Growth Through the PI3K‑Akt‑mTOR Signaling Pathways

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer

Journal of the American College of Surgeons
Surgery
2010English

Improved Therapy for Medulloblastoma: Targeting Hedgehog and PI3K-mTOR Signaling Pathways in Combination With Chemotherapy

Oncotarget
Oncology
2018English

Naringin Induces Autophagy-Mediated Growth Inhibition by Downregulating the PI3K/Akt/mTOR Cascade via Activation of MAPK Pathways in AGS Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy